April 2015 Issue Table Of Contents

From The Editor

• What Is The Biggest Challenge To Innovation In BioPharma?

Feature Articles

• Guiding Bayer’s Global Innovation Engines To New Heights
• Harmonized Post-Approval Changes: A Vaccine For Global Drug Shortages

The Enterprisers

• Agile Therapeutics: Reengineering Innovation

Capitol Perspectives

• Pending Supreme Court Decision On Obamacare Requires Solutions

Companies To Watch

• Resverlogix

Outsourcing Insights

• Biopharmaceutical Outsourcing To CROs In Emerging Markets Surges For 2015

Inside The Industry

• More Drugmakers Dip Into Social Media To Find And Engage Patients
• Liquid Courage – Evaluating Insider Liquidity
• How BARDA Is Helping Speed Up Drug Development/Manufacture
• Building A Patient Advocacy, Diversity, And Engagement Focus At BMS
• At Navidea, A Scientific Advisory Board Points To New Directions
• Diversifying Leadership Teams With People Who Have The X-Factor

Word From The Street

• Record Funding Year Changing How Companies Access Capital

Leadership Lessons

• Hiring Right Might Save Your Job

Industry Leader

• What Big Pharma Can Do To Combat The Latest Patent Cliff

Ask The Board

• Ask The Board